Page 24 - Ndpoint Threat Detection And Response News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ndpoint threat detection and response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ndpoint Threat Detection And Response Today - Breaking & Trending Today

Bristol Myers Squibb: Phase 3 CheckMate -901 Trial Fails To Meet Primary Endpoint

NEW YORK CITY (dpa-AFX) - Bristol Myers Squibb (BMY) said the phase 3 CheckMate -901 trial, comparing Opdivo plus Yervoy to standard-of-care chemotherapy as a first-line treatment for patients ....

Bristol Myers Squibb , Data Monitoring Committee , Myers Squibb ,

Genentech: Phase III Study In Non-Small Cell Lung Cancer Fails To Meet Co-primary Endpoint

SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, a member of the Roche Group (RHHBY), said that phase III SKYSCRAPER-01 study in PD-L1-High Metastatic Non-Small Cell Lung Cancer did not meet its co-primary ....

Roche Group , High Metastatic Non Small Cell Lung Cancer ,